Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 14 EU countries

Learn more

White Paper: Market access for medical devices in Europe: England, France, Germany, Italy and Spain

Get insights from MTRC White Papers to advance your understanding of European market access for medical devices

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Methodologies for generating and evaluating clinical and performance evidence for high-risk and innovative medical devices and in vitro diagnostics: a scoping review

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. 

In a recent publication, Bralić et al. conducted a scoping review of methodologies for generating and evaluating evidence for high-risk and innovative medical devices and in vitro diagnostics in the EU. The review included 98 studies and found that robust evaluation requires a combination of randomized trials, observational studies, registries, real-world evidence, and post-market surveillance. The authors also identified methodological limitations, inconsistent practices, and gaps in regulatory harmonization, emphasizing the need for a continuous and strategically planned lifecycle approach to evidence generation.

Access the full-text article here.